Simeon George discusses his early days at SR One while it was part of GSK, and the transition to making the firm independent in 2020. Plus, the importance of peer-to-peer collaboration, and his how he thinks about investing in different indications and modalities.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from BioVenture VoiCes with Chris Garabedian
Episode 41: Forbion's Nanna Lüneborg
Episode 40: GV's Krishna Yeshwant
Episode 39: SV Health Investors' Kate Bingham
Episode 38: Deerfield Management's Jason Fuller
Get summaries like this every morning.
Free AI-powered recaps of BioVenture VoiCes with Chris Garabedian and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.